Strs Ohio Allogene Therapeutics, Inc. Transaction History

Strs Ohio

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$6.78 - $12.28 $170,856 - $309,456	-25,200 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$13.13 - $24.52 $31,512 - $58,848	2,400 Added 10.53%	25,200 $375,000
Q2 2021 Jul 26, 2021	BUY	$23.49 - $35.8 $535,572 - $816,239	22,800 New	22,800 $594,000
Q1 2021 Apr 23, 2021	SELL	$25.79 - $39.02 $322,375 - $487,750	-12,500 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$25.24 - $43.45 $10,096 - $17,380	400 Added 3.31%	12,500 $315,000
Q3 2020 Dec 14, 2020	SELL	$32.38 - $44.96 $74,474 - $103,408	-2,300 Reduced 15.97%	12,100 $456,000
Q2 2020 Jul 23, 2020	BUY	$18.39 - $54.04 $264,816 - $778,176	14,400 New	14,400 $616,000
Q2 2019 Jul 25, 2019	SELL	$25.56 - $31.09 $148,248 - $180,322	-5,800 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$22.5 - $33.3 $130,500 - $193,139	5,800 New	5,800 $156,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.